Back to overview

Indian company ReproSci opens branch at Health Campus in Diepenbeek

This spring, high-tech company ReproSci Biosciences from India is opening a branch at the new Health Campus in Diepenbeek. This is the company’s first expansion outside Asia, initially employing six people.

The expansion is due to the efforts of POM Limburg and FIT India, the Indian branch of the Flemish export agency.

ReproSci Biosciences is a relatively young company specializing in fertility and reproductive healthcare. Based in Bangalore – the third largest city in India – the company operates in the femtech domain, an emerging sector in healthcare focusing on women-oriented solutions. According to forecasts, this sector will be worth around 55 billion euros in six years, with an annual growth rate of over 16 percent. Among other products, ReproSci developed the Fertilator, a virtual reality simulator aimed at egg retrieval procedures.

ReproSci had been planning European expansion for some time and explicitly chose the new Health Campus in Diepenbeek. This is mainly due to the efforts of the Flemish export and investment agency Flanders Investment and Trade (FIT) India and POM Limburg. ReproSci sought a central base for its international activities and found it in Limburg. Vijaygopal Rengarajan, CEO of ReproSci, stated, “We are pleased to be part of the dynamic ecosystem of Health Campus Limburg DC. This collaboration with the university and nearby hospitals enables us to advance technological progress in medical education through simulation-based training. Together, we aim to revolutionize medical training so that healthcare professionals are better prepared and can achieve better outcomes. This is a significant milestone in ReproSci’s growth and innovation journey, especially for our flagship product, the Fertilator, and beyond.”

The arrival of ReproSci perfectly fits the ecosystem that POM Limburg is building on the Health Campus. Deputy for Economy and Chairman of POM Limburg, Tom Vandeput, said, “Thanks to the established reputation of UHasselt in biomedical sciences and the facilities of BioVille, another promising start-up found its way to Diepenbeek. The innovative environment of the campus and its growing ecosystem play a crucial role in this decision. As a femtech company, ReproSci complements this ecosystem nicely. Their arrival is yet another confirmation of the campus’s position in Flanders and beyond.”

FIT is also pleased with the arrival of the Indian player. Spokesperson Desna Lespinoy commented, “ReproSci has achieved great things for women in India through their extensive research and expertise in biosciences. This makes them an excellent partner for Flanders, where we are among the leaders in this field. FIT is excited to expand this important ecosystem by connecting two pioneering players in this area. Research in women’s healthcare is crucial, both medically and in terms of working towards global gender equality. We look forward to their future achievements together.


  • (Optional)
  • This field is for validation purposes and should be left unchanged.

We use cookies or similar technologies (e.g. pixels or social media plug-ins) to optimise your user experience on our website, among other things. In addition, we wish to use analytical and marketing cookies to personalise your visit to our website, to send targeted advertisements to you, and to give us more insight into your use of our website.

Do you consent to our use of cookies for an optimal website experience, so that we can improve our website and surprise you with advertisements? Then confirm with ‘OK’.

Conversely, would you like to set specific preferences for different types of cookies? This can be done via our Cookie Policy. Would you like more information about our use of cookies or how to delete cookies? Please read our Cookie Policy.